To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
HIV blood screeningThe risk of transmitting HIV infection to blood transfusion recipients has been drastically reduced by improved donor selection and sensitive serologic screening assays in many countries. In 2000, WHO estimated that 1 million new HIV infections around the world resulted from inadequate blood screening. Additional recommended knowledgeScreening tests require a high degree of confidence that HIV is not present, so a combination of antibody (serology), antigen and nucleic acid based tests are used by blood banks in Western countries. The average window period with antibody tests is 22 days. Antigen testing cuts the window period to approximately 16 days and NAT further reduces this period to 12 days. FDA 2001 Public demand in the United States for HIV blood screening arose during the campaign to re elect President Ronald Reagan. In April 1984, U.S. Health and Human Services Secretary Margaret Heckler announced to the world at a press conference that an American scientist, Dr. Robert Gallo, had discovered the probable cause of acquired immune deficiency syndrome AIDS: the retrovirus subsequently named Human Immunodeficiency Virus HIV. The first screening test, an ELISA antibody test, had a high sensitivity but a low specificity. The low specificity of the test is due to cross-reacting antibodies, which attach to HIV particles "by accident", even though the body has never encountered HIV. Antibody tests cannot detect recent HIV infections, because there is a window period of several weeks between infection and the production of antibodies. Antigen and nucleic acid based tests have been introduced in some countries to reduce this window period. Timeline
Categories: Transfusion medicine | HIV/AIDS |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "HIV_blood_screening". A list of authors is available in Wikipedia. |